Jaffetilchin Investment Partners LLC Acquires 670 Shares of Johnson & Johnson (NYSE:JNJ)

Share on StockTwits

Jaffetilchin Investment Partners LLC grew its position in shares of Johnson & Johnson (NYSE:JNJ) by 4.1% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 16,916 shares of the company’s stock after acquiring an additional 670 shares during the quarter. Jaffetilchin Investment Partners LLC’s holdings in Johnson & Johnson were worth $2,518,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Newfound Research LLC acquired a new position in Johnson & Johnson during the 3rd quarter worth approximately $28,000. Islay Capital Management LLC acquired a new position in Johnson & Johnson during the 2nd quarter worth approximately $42,000. FAI Wealth Management boosted its position in Johnson & Johnson by 45.9% during the 2nd quarter. FAI Wealth Management now owns 321 shares of the company’s stock worth $45,000 after acquiring an additional 101 shares during the last quarter. SeaBridge Investment Advisors LLC boosted its position in Johnson & Johnson by 160.0% during the 2nd quarter. SeaBridge Investment Advisors LLC now owns 325 shares of the company’s stock worth $46,000 after acquiring an additional 200 shares during the last quarter. Finally, HWG Holdings LP acquired a new position in Johnson & Johnson during the 2nd quarter worth approximately $49,000. 67.44% of the stock is owned by hedge funds and other institutional investors.

Shares of Johnson & Johnson stock opened at $146.36 on Friday. The business has a fifty day simple moving average of $145.51 and a two-hundred day simple moving average of $146.57. Johnson & Johnson has a 1 year low of $109.16 and a 1 year high of $157.00. The company has a market capitalization of $385.30 billion, a price-to-earnings ratio of 23.01, a P/E/G ratio of 3.04 and a beta of 0.69. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.48 and a quick ratio of 1.24.

Johnson & Johnson (NYSE:JNJ) last announced its quarterly earnings results on Sunday, October 18th. The company reported $2.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.98 by $0.22. The business had revenue of $21.08 billion during the quarter, compared to the consensus estimate of $20.15 billion. Johnson & Johnson had a return on equity of 34.64% and a net margin of 21.01%. The company’s quarterly revenue was up 1.7% on a year-over-year basis. During the same quarter last year, the firm posted $2.12 EPS. As a group, equities analysts anticipate that Johnson & Johnson will post 7.99 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 8th. Shareholders of record on Tuesday, November 24th will be given a dividend of $1.01 per share. This represents a $4.04 annualized dividend and a yield of 2.76%. The ex-dividend date is Monday, November 23rd. Johnson & Johnson’s payout ratio is 46.54%.

JNJ has been the subject of a number of recent research reports. Cantor Fitzgerald upped their price target on Johnson & Johnson from $168.00 to $180.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 14th. ValuEngine raised Johnson & Johnson from a “sell” rating to a “hold” rating in a report on Monday, August 3rd. Stifel Nicolaus downgraded Johnson & Johnson from a “buy” rating to a “hold” rating in a report on Wednesday, August 19th. Credit Suisse Group increased their price objective on Johnson & Johnson from $163.00 to $168.00 and gave the company an “outperform” rating in a report on Wednesday, October 14th. Finally, Raymond James reissued a “buy” rating on shares of Johnson & Johnson in a report on Friday. One research analyst has rated the stock with a sell rating, four have given a hold rating and ten have assigned a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $164.93.

In other Johnson & Johnson news, EVP Kathryn E. Wengel sold 16,115 shares of the stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $153.52, for a total transaction of $2,473,974.80. Following the transaction, the executive vice president now owns 66,658 shares in the company, valued at approximately $10,233,336.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.27% of the stock is owned by company insiders.

Johnson & Johnson Company Profile

Johnson & Johnson researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DR.

Recommended Story: NASDAQ

Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Johnson & Johnson  Shares Bought by Edge Capital Group LLC
Johnson & Johnson Shares Bought by Edge Capital Group LLC
The Manufacturers Life Insurance Company Purchases 8,738 Shares of Paychex, Inc.
The Manufacturers Life Insurance Company Purchases 8,738 Shares of Paychex, Inc.
The Manufacturers Life Insurance Company Has $28.42 Million Holdings in Paychex, Inc.
The Manufacturers Life Insurance Company Has $28.42 Million Holdings in Paychex, Inc.
The Manufacturers Life Insurance Company Trims Position in MetLife, Inc.
The Manufacturers Life Insurance Company Trims Position in MetLife, Inc.
Jaffetilchin Investment Partners LLC Acquires 670 Shares of Johnson & Johnson
Jaffetilchin Investment Partners LLC Acquires 670 Shares of Johnson & Johnson
The Manufacturers Life Insurance Company Trims Position in MetLife, Inc.
The Manufacturers Life Insurance Company Trims Position in MetLife, Inc.


 
© 2006-2020 Zolmax.